Table 2.
Measure | Time point | ||
---|---|---|---|
BL | 20-wk | 6-mo | |
Informed Consent | X | ||
Screening Questionnaires: | X | ||
Alcohol Use Disorders Identification Test (AUDIT) | |||
Drug Abuse Screen Test (DAST-10) | |||
Pregnancy test (urine), if applicable | X | ||
2-minute step in place test | X | X | X |
Resting HR, oxygen saturation and blood pressure | X | X | X |
Weight | X | X | X |
Spirometry | X | X | X |
Muscle Strength | X | X | X |
Neurosensory integrity | X | X | X |
Physical activity and HR/HR variability | X | X | X |
Questionnaire: | X | X | X |
Physical activity Readiness Questionnaire (PAR-Q) | |||
Questionnaires: | X | X | X |
Physical Activity Related Health History | |||
Patient Health Questionnaire (PHQ-8) | |||
Generalized Anxiety Disorder (GAD-7) | |||
PROMIS Ability to Participate 8a (SF v2.0) | |||
Work Productivity and Activity Impairment Questionnaire (WPAI) | |||
Work and Social Adjustment Scale (WSAS) | |||
Medical Outcomes Survey Short Form (SF-36) | |||
Childhood Cancer Survivor Study Neurocognitive | |||
Questionnaire – Revised (CCSS-NCQ) | |||
Questionnaire (Acceptability Measures): | X | X | |
Service User Technology Acceptability Questionnaire (SUTAQ) | |||
System Usability Scale (SUS) | |||
OPTIONAL: Biomarkers (saliva), if applicable | X | X | X |
Abbreviations: BL, baseline; HR, heart rate; mo, month; wk, week